Results from a Phase 2 Study of Ruxolitinib or Placebo with Capecitabine as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer: The Recap Trial


Journal Article

Full Text

Duke Authors

Cited Authors

  • Hurwitz, H; Uppal, N; Wagner, SA; Bendell, J; Thaddeus, BJ; Wade, S; Nemunaitis, J; Stella, P; Pipas, JM; Wainberg, Z; Manges, R; Garrett, W; Hunter, D; Clark, J; Leopold, L; Levy, R; Sandor, V

Published Date

  • June 1, 2014

Published In

Volume / Issue

  • 25 /

Start / End Page

  • ii115 -

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdu193.26

Citation Source

  • Scopus